Drug intelligence / Profile preview

LSDV vaccine

Development stage
Preclinical
Lead developer
TVG
Modality
Viral Vector Vaccines → Recombinant Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
Administration
Subcutaneous
01

Overview

TVG's LSDV vaccine is a herpesvirus-based viral-vector vaccine designed to protect cattle against Lumpy Skin Disease Virus (LSDV). Developed by The Vaccine Group (TVG), the vaccine utilizes a proprietary herpesvirus vector platform to express LSDV antigens, aiming to induce protective immunity. Preclinical studies have demonstrated immunogenicity in calves. This approach leverages the ability of herpesviruses to induce robust and long-lasting immune responses in livestock, potentially offering a more effective alternative to traditional live-attenuated vaccines.

Other names
Lumpy skin disease vaccineTVG-LSDVTVG-Lumpy Skin Disease Virus antigen-herpesvirus-based viral-vector vaccine-Lumpy skin disease in cattle

Beyond the preview

Go deeper on LSDV vaccine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on LSDV vaccine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call